205 related articles for article (PubMed ID: 34639035)
1. 3-Pyridinylidene Derivatives of Chemically Modified Lupane and Ursane Triterpenes as Promising Anticancer Agents by Targeting Apoptosis.
Kazakova O; Șoica C; Babaev M; Petrova A; Khusnutdinova E; Poptsov A; Macașoi I; Drăghici G; Avram Ș; Vlaia L; Mioc A; Mioc M; Dehelean C; Voicu A
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639035
[TBL] [Abstract][Full Text] [Related]
2. Novel Synthesized
Kazakova O; Mioc A; Smirnova I; Baikova I; Voicu A; Vlaia L; Macașoi I; Mioc M; Drăghici G; Avram Ş; Dehelean C; Şoica C
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681629
[TBL] [Abstract][Full Text] [Related]
3. Hollongdione arylidene derivatives induce antiproliferative activity against melanoma and breast cancer through pro-apoptotic and antiangiogenic mechanisms.
Smirnova I; Drăghici G; Kazakova O; Vlaia L; Avram S; Mioc A; Mioc M; Macaşoi I; Dehelean C; Voicu A; Şoica C
Bioorg Chem; 2022 Feb; 119():105535. PubMed ID: 34906859
[TBL] [Abstract][Full Text] [Related]
4. Natural Product Triterpenoids and Their Semi-Synthetic Derivatives with Potential Anticancer Activity.
Ren Y; Kinghorn AD
Planta Med; 2019 Aug; 85(11-12):802-814. PubMed ID: 30658371
[TBL] [Abstract][Full Text] [Related]
5. Known Triterpenes and their Derivatives as Scaffolds for the Development of New Therapeutic Agents for Cancer.
Peron G; Marzaro G; Dall Acqua S
Curr Med Chem; 2018; 25(10):1259-1269. PubMed ID: 28820068
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterisation of celastrol derivatives as potential anticancer agents.
Zhang HJ; Zhang GR; Piao HR; Quan ZS
J Enzyme Inhib Med Chem; 2017 Dec; 33(1):190-198. PubMed ID: 29231066
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of β-boswellic acid derivatives as cytotoxic and apoptotic agents.
Kumar A; Qayum A; Sharma PR; Singh SK; Shah BA
Bioorg Med Chem Lett; 2016 Jan; 26(1):76-81. PubMed ID: 26608550
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, proapoptotic screening, and structure-activity relationships of novel aza-lupane triterpenoids.
Mar AA; Szotek EL; Koohang A; Flavin WP; Eiznhamer DA; Flavin MT; Xu ZQ
Bioorg Med Chem Lett; 2010 Sep; 20(18):5389-93. PubMed ID: 20719505
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and mechanism studies of C-23 modified 23-hydroxybetulinic acid derivatives as anticancer agents.
Lu L; Zhang H; Liu J; Liu Y; Wang Y; Xu S; Zhu Z; Xu J
Eur J Med Chem; 2019 Nov; 182():111659. PubMed ID: 31491611
[TBL] [Abstract][Full Text] [Related]
10. Small structural changes of pentacyclic lupane type triterpenoid derivatives lead to significant differences in their anticancer properties.
Kommera H; Kaluderović GN; Kalbitz J; Dräger B; Paschke R
Eur J Med Chem; 2010 Aug; 45(8):3346-53. PubMed ID: 20472329
[TBL] [Abstract][Full Text] [Related]
11. Novel A-Ring Chalcone Derivatives of Oleanolic and Ursolic Amides with Anti-Proliferative Effect Mediated through ROS-Triggered Apoptosis.
Khusnutdinova E; Petrova A; Zileeva Z; Kuzmina U; Zainullina L; Vakhitova Y; Babkov D; Kazakova O
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575964
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Anticancer Evaluation of Novel Indole Derivatives of Ursolic Acid as Potential Topoisomerase II Inhibitors.
Li AL; Hao Y; Wang WY; Liu QS; Sun Y; Gu W
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326071
[TBL] [Abstract][Full Text] [Related]
13. Novel celastrol derivatives with improved selectivity and enhanced antitumour activity: Design, synthesis and biological evaluation.
Figueiredo SAC; Salvador JAR; Cortés R; Cascante M
Eur J Med Chem; 2017 Sep; 138():422-437. PubMed ID: 28688281
[TBL] [Abstract][Full Text] [Related]
14. Ring A-modified Derivatives from the Natural Triterpene 3-O-acetyl-11-keto-β-Boswellic Acid and their Cytotoxic Activity.
Li T; Fan P; Ye Y; Luo Q; Lou H
Anticancer Agents Med Chem; 2017; 17(8):1153-1167. PubMed ID: 27928954
[TBL] [Abstract][Full Text] [Related]
15. New lupane derived compounds with pro-apoptotic activity in cancer cells: synthesis and structure-activity relationships.
Sarek J; Klinot J; Dzubák P; Klinotová E; Nosková V; Krecek V; Korínková G; Thomson JO; Janost'áková A; Wang S; Parsons S; Fischer PM; Zhelev NZ; Hajdúch M
J Med Chem; 2003 Dec; 46(25):5402-15. PubMed ID: 14640549
[TBL] [Abstract][Full Text] [Related]
16. Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds.
Abdelhafez OM; Ahmed EY; Abdel Latif NA; Arafa RK; Abd Elmageed ZY; Ali HI
Bioorg Med Chem; 2019 Apr; 27(7):1308-1319. PubMed ID: 30792101
[TBL] [Abstract][Full Text] [Related]
17. 3'-(4-(Benzyloxy)phenyl)-1'-phenyl-5-(heteroaryl/aryl)-3,4-dihydro-1'H,2H-[3,4'-bipyrazole]-2-carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies.
Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Pottoo FH; Jha M
Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900262. PubMed ID: 32003485
[TBL] [Abstract][Full Text] [Related]
18. Betulin-1,4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme.
Kadela-Tomanek M; Bębenek E; Chrobak E; Marciniec K; Latocha M; Kuśmierz D; Jastrzębska M; Boryczka S
Eur J Med Chem; 2019 Sep; 177():302-315. PubMed ID: 31158746
[TBL] [Abstract][Full Text] [Related]
19. New phosphate derivatives of betulin as anticancer agents: Synthesis, crystal structure, and molecular docking study.
Chrobak E; Kadela-Tomanek M; Bębenek E; Marciniec K; Wietrzyk J; Trynda J; Pawełczak B; Kusz J; Kasperczyk J; Chodurek E; Paduszyński P; Boryczka S
Bioorg Chem; 2019 Jun; 87():613-628. PubMed ID: 30947097
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel potent inhibitors against Bcl-xL anti-apoptotic protein using docking studies.
Shipra G; Gauri M; Chandra PM; Kishore SP
Protein Pept Lett; 2012 Dec; 19(12):1302-17. PubMed ID: 22670675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
